Skip to content
10-K

Annual Report

Journey Medical Corp DERM

0001104659-26-034629

← back to feed
Filed
Mar 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 24.5M sh
Shares Diluted FY 2025 · Dec 31, 2024 20.43M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$12.44M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$9.13M
Long Term Debt FY 2025 · Dec 31, 2025 $25.28M
Long Term Debt FY 2025 · Dec 31, 2024 $24.88M
Cash And Equivalents FY 2025 · Dec 31, 2025 $24.09M
Cash And Equivalents FY 2025 · Dec 31, 2024 $20.31M
Stockholders Equity FY 2025 · Dec 31, 2025 $31.85M
Stockholders Equity FY 2025 · Dec 31, 2024 $20.07M
Stockholders Equity FY 2025 · Dec 31, 2023 $20.35M
Current Liabilities FY 2025 · Dec 31, 2025 $37.44M
Current Liabilities FY 2025 · Dec 31, 2024 $35.18M
Total Liabilities FY 2025 · Dec 31, 2025 $62.74M
Total Liabilities FY 2025 · Dec 31, 2024 $60.17M
Current Assets FY 2025 · Dec 31, 2025 $66.87M
Current Assets FY 2025 · Dec 31, 2024 $48.18M
Total Assets FY 2025 · Dec 31, 2025 $94.59M
Total Assets FY 2025 · Dec 31, 2024 $80.24M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.47
Eps Diluted FY 2025 · Dec 31, 2024 −$0.72
Eps Basic FY 2025 · Dec 31, 2025 −$0.47
Eps Basic FY 2025 · Dec 31, 2024 −$0.72
Sga Expense FY 2025 · Dec 31, 2025 $44.37M
Sga Expense FY 2025 · Dec 31, 2024 $40.2M
Rd Expense FY 2025 · Dec 31, 2025 $480K
Rd Expense FY 2025 · Dec 31, 2024 $9.86M
Net Income FY 2025 · Dec 31, 2025 −$11.43M
Net Income FY 2025 · Dec 31, 2024 −$14.67M
Operating Income FY 2025 · Dec 31, 2025 −$8.17M
Operating Income FY 2025 · Dec 31, 2024 −$13.68M
Cost Of Revenue FY 2025 · Dec 31, 2025 $20.92M
Cost Of Revenue FY 2025 · Dec 31, 2024 $20.88M
Revenue FY 2025 · Dec 31, 2025 $61.24M
Revenue FY 2025 · Dec 31, 2024 $55.13M
Capex FY 2025 · Dec 31, 2024 $15M